-
China Resources Chemical Innovative Materials Holdings Received US$25 Million Investment fromChina Resources Chemical Innovative Materials Holdings has recently received US$25 million investment from British BP Petroleum, which has thus become one of the shareholders, whilst the parties entered into a strategic cooperation agreement to strengthen cooperation in the procurement of refined terephthalic acid (PTA) which is the raw material in the production of polyethylene terephthalate (PET). This would engage both upstream and downstream industrial chains in practic...04/10/2020
-
CR Land Raises HK$6.72 Billion through Share PlacementOn 21 October, with Goldman Sachs (Asia) L.L.C. as the placing agent, China Resources Land(”CR Land”)placed a total of 200 million shares through a placing of existing shares and top-up subscription for new shares. The placing price of HK$33.65 per share represented a discount of approximately 6.9% to the closing price of the last trading day. The total number of placing shares represented approximately 2.9% of the issued share capital of the Company as at the date of the a...10/22/2019
-
CR Property’s All Seasons Property Launches “Chinese Products Fair” in ThailandIn order to promote Chinese brands and strengthen cooperation among Chinese enterprises in Thailand and under the guidance of the Chinese-Thai Enterprises Association. All Seasons Property, a subsidiary of CR Property, fully leveraged the resources and facilities of the urban complex All Seasons Place and launched a “Chinese Products Fair” in Thailand. The fair aims to promote Chinese products and help Thailand-based Chinese companies to explore new markets and customers s...09/24/2019
-
CR Sanjiu Enters into Strategic Cooperation Agreement with RyukakusanOn 14 August, China Resources Sanjiu (“CR Sanjiu”) announced that it entered into a strategic cooperation agreement with Ryukakusan, a renowned Japanese pharmaceutical company that develops throat and swallowing products, at the 2019 China Pharmaceutical Enterprises Co-operation and Development Organization Summit. This was another major move by CR Sanjiu following its cross-border cooperation with Sanofi and Goodbaby.08/19/2019
-
China Resources Sanjiu included in FTSE Russell Global IndexRecently, China Resources Sanjiu (CR Sanjiu) has been included by leading international index company FTSE Russell in its global index. This inclusion came into effect after the A-share market close on June 21.06/21/2019
-
CR Snow and Heineken Group hold strategic cooperation ceremonyOn April 13, 2019, China Resources Snow (CR Snow) and the Heineken Group held a strategic cooperation ceremony in Shanghai, during which both sides conducted in-depth discussions on joint-venture cooperation. Dr. Fu Yuning, the Chairman of China Resources Group also attended the ceremony.04/16/2019
-
Shenzhen Runlian Intelligent Technology Officially LaunchedOn the morning of February 26, 2019, the inauguration ceremony of Shenzhen Runlian Intelligent Technology Co., Ltd. (Shenzhen Runlian Intelligent Technology) was held in Shenzhen. CRG vice general manager, Mr. Li Fuli and Chief Information Officer (CIO), Mrs. Wang Peihui attended the ceremony, along with responsible persons of the Group's Intelligence and Information Technology Department and Runlian Intelligent Technology.03/02/2019
-
CR Pharma Wins BDO ESG Awards 2019On February 20, 2019, the second “Outstanding Environmental, Social and Governance (ESG) Award”, which was hosted by BDO Hong Kong and co-organized by South China Morning Post, was unveiled in Hong Kong. China Resources Pharmaceutical Group Limited (CR Pharma), with its high environment, society and governance (ESG) standards, won the "ESG Award for Company of the Year (Newly Listed Company)" and the "ESG Award for Best Performance ".02/25/2019
-
CR Power Ranks 8th in HKBSIChina Resources Power (CR Power) took the eighth spot on the Hong Kong Business Sustainability Index" (HKBSI) released on January 7, 2019, marking the fourth time the Company has made to the top 20 HSI enterprises in the index.01/08/2019
-
CR Pharma Comm signs comprehensive strategic cooperation agreement with GILD of USOn November 1, China Resources Pharmaceutical Commerce (CR Pharma Comm) and the Gilead Sciences (GILD) of the United States jointly released the world's leading anti-viral treatment plan for infectious diseases and signed a comprehensive strategic cooperation agreement in Shanghai.11/02/2018
Press Releases